Sangeda Raphael Z, William Sahani M, Masatu Faustine C, Bitegeko Adonis, Mwalwisi Yonah H, Nkiligi Emmanuel A, Horumpende Pius G, Fimbo Adam M
Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania.
Medicines Control, Tanzania Medicines and Medical Devices Authority, P.O. Box 1253, Dodoma, Tanzania.
JAC Antimicrob Resist. 2024 May 27;6(3):dlae081. doi: 10.1093/jacamr/dlae081. eCollection 2024 Jun.
Antimicrobial resistance (AMR) is a growing public health concern globally, and misuse of antibiotics is a major contributor.
This study investigated antibiotic utilization patterns before and during the COVID-19 pandemic in Tanzania using data from the Tanzania Medicines and Medical Devices Authority (TMDA).
This retrospective longitudinal study analysed secondary data. The study compared antibiotics consumption in defined daily doses per 1000 inhabitants per day (DID) in two distinct eras: 2018-2019 as the pre-COVID-19 era and 2020-2021 as the intra-COVID-19 era. A sample -test was conducted using Statistical Package for the Social Sciences.
The study analysed 10 614 records and found an overall increase in antibiotics consumption from 2018 to 2021. We found that the consumption was 61.24 DID in the intra-COVID-19 era and 50.32 DID in the pre-COVID-19 era. Levofloxacin had the highest percentage increase in use, with a 700% increase in DID during the intra-COVID-19 era. Azithromycin had a 163.79% increase, while cefotaxime had a 600% increase. By contrast, some antibiotics exhibited a decrease in usage during the intra-COVID-19 era, such as nalidixic acid, which had a 100% decrease, and cefpodoxime, which had a 66.67% decrease.
Increased antibiotic consumption during the COVID-19 pandemic highlights the importance of implementing effective antimicrobial stewardship strategies to prevent AMR, especially during pandemics.
抗菌药物耐药性(AMR)是全球日益严重的公共卫生问题,抗生素的滥用是主要促成因素。
本研究利用坦桑尼亚药品和医疗器械管理局(TMDA)的数据,调查了坦桑尼亚在2019冠状病毒病大流行之前和期间的抗生素使用模式。
这项回顾性纵向研究分析了二手数据。该研究比较了两个不同时期每1000居民每天规定日剂量(DID)的抗生素消费量:2018 - 2019年为2019冠状病毒病大流行前时期,2020 - 2021年为2019冠状病毒病大流行期间。使用社会科学统计软件包进行抽样检验。
该研究分析了10614条记录,发现2018年至2021年抗生素消费量总体上升。我们发现,在2019冠状病毒病大流行期间,消费量为6 1.24规定日剂量,在2019冠状病毒病大流行前时期为50.32规定日剂量。左氧氟沙星的使用量增长百分比最高,在2019冠状病毒病大流行期间规定日剂量增加了700%。阿奇霉素增加了163.79%,而头孢噻肟增加了600%。相比之下,一些抗生素在2019冠状病毒病大流行期间使用量有所下降,如萘啶酸下降了100%,头孢泊肟下降了66.67%。
2019冠状病毒病大流行期间抗生素消费量增加凸显了实施有效的抗菌药物管理策略以预防抗菌药物耐药性的重要性,尤其是在大流行期间。